Thus, all these results suggest that a modulation of the NRF2-TFAM pathway is unlikely involved in the effects provided by NOX4 inhibition in the spinal cord of severe type SMA-like mice. The gene discussed is TFAM; the disease is proximal spinal muscular atrophy.